Gambogic amide inhibits angiogenesis by suppressing VEGF/VEGFR2 in endothelial cells in a TrkA-independent manner

References

• Ahir BK, Engelhard HH, Lakka SS. 2020. Tumor development and angiogenesis in adult brain tumor: Glioblastoma. Mol Neurobiol. 57(5):2461–2478.
   PubMed Web of Science ®Google Scholar
• Ameratunga M, Pavlakis N, Wheeler H, Grant R, Simes J, Khasraw M. 2018. Anti-angiogenic therapy for high-grade glioma. Cochrane Database Syst Rev. 11:CD008218.
   PubMedGoogle Scholar
• Assareh E, Mehrnejad F, Mansouri K, Esmaeili Rastaghi AR, Naderi-Manesh H, Asghari SM. 2019. A cyclic peptide reproducing the α1 helix of VEGF-B binds to VEGFR-1 and VEGFR-2 and inhibits angiogenesis and tumor growth. Biochem J. 476(4):645–663.
   PubMedGoogle Scholar
• Carmeliet P, Jain RK. 2011. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov. 10(6):417–427.
   PubMed Web of Science ®Google Scholar
• Chan CB, Liu X, Jang SW, Hsu SI, Williams I, Kang S, Chen J, Ye K. 2009. NGF inhibits human leukemia proliferation by downregulating cyclin A1 expression through promoting acinus/CtBP2 association. Oncogene. 28(43):3825–3836.
   PubMed Web of Science ®Google Scholar
• Chen Z, Gao Y, Gao S, Song D, Feng Y. 2020. MiR-135b-5p promotes viability, proliferation, migration and invasion of gastric cancer cells by targeting Krüppel-like factor 4 (KLF4). Arch Med Sci. 16(1):167–176.
   PubMed Web of Science ®Google Scholar
• Cheung N, Mitchell P, Wong TY. 2010. Diabetic retinopathy. Lancet. 376(9735):124–136.
   PubMed Web of Science ®Google Scholar
• Chow DS, Horenstein CI, Canoll P, Lignelli A, Hillman EM, Filippi CG, Grinband J. 2016. Glioblastoma induces vascular dysregulation in nonenhancing peritumoral regions in humans. Am J Roentgenol. 206(5):1073–1081.
   PubMed Web of Science ®Google Scholar
• De Bock K, Cauwenberghs S, Carmeliet P. 2011. Vessel abnormalization: another hallmark of cancer? Molecular mechanisms and therapeutic implications. Curr Opin Genet Dev. 21(1):73–79.
   PubMed Web of Science ®Google Scholar
• Eggert A, Grotzer MA, Ikegaki N, Liu XG, Evans AE, Brodeur GM. 2000. Expression of neurotrophin receptor TrkA inhibits angiogenesis in neuroblastoma. Med Pediatr Oncol. 35(6):569–572.
   PubMedGoogle Scholar
• Eggert A, Grotzer MA, Ikegaki N, Liu XG, Evans AE, Brodeur GM. 2002. Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cells. Cancer Res. 62(6):1802–1808.
   PubMed Web of Science ®Google Scholar
• Ellis LM, Hicklin DJ. 2008. Pathways mediating resistance to vascular endothelial growth factor-targeted therapy. Clin Cancer Res. 14(20):6371–6375.
   PubMed Web of Science ®Google Scholar
• Farzaneh Behelgardi M, Zahri S, Mashayekhi F, Mansouri K, Asghari SM. 2018. A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis. Sci Rep. 8(1):17924–17936.
   PubMedGoogle Scholar
• Flores-Arriaga JC, de J, Pozos-Guillen A, Escobar-Garcia DM, Grandfils C, Cerda-Cristerna BI. 2017. Cell viability and hemocompatibility evaluation of a starch-based hydrogel loaded with hydroxyapatite or calcium carbonate for maxillofacial bone regeneration. Odontology. 105(4):398–407.
   PubMed Web of Science ®Google Scholar
• Folkman J. 1971. Tumor angiogenesis: therapeutic implications. N Engl J Med. 285(21):1182–1186.
   PubMed Web of Science ®Google Scholar
• Fu Z, Chen X, Guan S, Yan Y, Lin H, Hua ZC. 2015. Curcumin inhibits angiogenesis and improves defective hematopoiesis induced by tumor-derived VEGF in tumor model through modulating VEGF-VEGFR2 signaling pathway. Oncotarget. 6(23):19469–19482.
   PubMedGoogle Scholar
• Garrido MP, Torres I, Avila A, Chnaiderman J, Valenzuela-Valderrama M, Aramburo J, Orostica L, Duran-Jara E, Lobos-Gonzalez L, Romero C. 2020. NGF/TRKA decrease miR-145-5p levels in epithelial ovarian cancer cells. IJMS. 21(20):7657–7677.
   Google Scholar
• Gho Y, Shin SS, Choi YH, Ko K, Kim WJ, Moon SK. 2019. Hydrangenol suppresses VEGF-stimulated angiogenesis by targeting p27KIP1-dependent G1-cell cycle arrest, VEGFR-2-mediated signaling, and MMP-2 expression. Anim Cells Syst. 23(2):72–81.
   PubMed Web of Science ®Google Scholar
• Greenberg ME, Xu B, Lu B, Hempstead BL. 2009. New insights in the biology of BDNF synthesis and release: implications in CNS function. J Neurosci. 29(41):12764–12767.
   PubMed Web of Science ®Google Scholar
• Hassanpour M, Rezabakhsh A, Pezeshkian M, Rahbarghazi R, Nouri M. 2018. Distinct role of autophagy on angiogenesis: highlights on the effect of autophagy in endothelial lineage and progenitor cells. Stem Cell Res Ther. 9(1):305–320.
   PubMedGoogle Scholar
• Hassanpour M, Rezabakhsh A, Rahbarghazi R, Nourazarian A, Nouri M, Avci CB, Ghaderi S, Alidadyani N, Bagca BG, Bagheri HS. 2017. Functional convergence of Akt protein with VEGFR-1 in human endothelial progenitor cells exposed to sera from patient with type 2 diabetes mellitus. Microvasc Res. 114:101–113.
   PubMed Web of Science ®Google Scholar
• Hatami E, Jaggi M, Chauhan SC, Yallapu MM. 2020. Gambogic acid: a shining natural compound to nanomedicine for cancer therapeutics. Biochim Biophys Acta Rev Cancer. 1874(1):188381–188420.
   PubMed Web of Science ®Google Scholar
• Hirose M, Kuroda Y, Murata E. 2016. NGF/TrkA signaling as a therapeutic target for pain. Pain Pract. 16(2):175–182.
   PubMed Web of Science ®Google Scholar
• Hu WH, Wang HY, Kong XP, Xiong QP, Poon KK, Xu L, Duan R, Chan GK, Dong TT, Tsim KW. 2019. Polydatin suppresses VEGF-induced angiogenesis through binding with VEGF and inhibiting its receptor signaling. FASEB J. 33(1):532–544.
   PubMed Web of Science ®Google Scholar
• Hu PS, Xia QS, Wu F, Li DK, Qi YJ, Hu Y, Wei ZZ, Li SS, Tian NY, Wei QF, et al. 2017. NSPc1 promotes cancer stem cell self-renewal by repressing the synthesis of all-trans retinoic acid via targeting RDH16 in malignant glioma. Oncogene. 36(33):4706–4718.
   PubMed Web of Science ®Google Scholar
• Hu Y, Zhang M, Tian N, Li D, Wu F, Hu P, Wang Z, Wang L, Hao W, Kang J, et al. 2019. The antibiotic clofoctol suppresses glioma stem cell proliferation by activating KLF13. J Clin Invest. 129(8):3072–3085.
   PubMed Web of Science ®Google Scholar
• Jang SW, Okada M, Sayeed I, Xiao G, Stein D, Jin P, Ye K. 2007. Gambogic amide, a selective agonist for TrkA receptor that possesses robust neurotrophic activity, prevents neuronal cell death. Proc Natl Acad Sci USA. 104(41):16329–16334.
   PubMed Web of Science ®Google Scholar
• Jia B, Li S, Hu X, Zhu G, Chen W. 2015. Recent research on bioactive xanthones from natural medicine: Garcinia hanburyi. AAPS PharmSciTech. 16(4):742–758.
   PubMed Web of Science ®Google Scholar
• Kerbel RS, Kamen BA. 2004. The anti-angiogenic basis of metronomic chemotherapy. Nat Rev Cancer. 4(6):423–436.
   PubMed Web of Science ®Google Scholar
• Kim DW, Huamani J, Fu A, Hallahan DE. 2006. Molecular strategies targeting the host component of cancer to enhance tumor response to radiation therapy. Int J Radiat Oncol Biol Phys. 64(1):38–46.
   PubMed Web of Science ®Google Scholar
• Kruttgen A, Schneider I, Weis J. 2006. The dark side of the NGF family: neurotrophins in neoplasias. Brain Pathol. 16(4):304–310.
   PubMed Web of Science ®Google Scholar
• Lagadec C, Meignan S, Adriaenssens E, Foveau B, Vanhecke E, Romon R, Toillon RA, Oxombre B, Hondermarck H, Le Bourhis X. 2009. TrkA overexpression enhances growth and metastasis of breast cancer cells. Oncogene. 28(18):1960–1970.
   PubMed Web of Science ®Google Scholar
• Lu J, Wu DM, Hu B, Zheng YL, Zhang ZF, Wang YJ. 2010. NGF-Dependent activation of TrkA pathway: a mechanism for the neuroprotective effect of troxerutin in d-galactose-treated mice. Brain Pathol. 20(5):952–965.
   PubMed Web of Science ®Google Scholar
• Mazzone M, Dettori D, de Oliveira RL, Loges S, Schmidt T, Jonckx B, Tian YM, Lanahan AA, Pollard P, de Almodovar CR, et al. 2009. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell. 136(5):839–851.
   PubMed Web of Science ®Google Scholar
• Molloy NH, Read DE, Gorman AM. 2011. Nerve growth factor in cancer cell death and survival. Cancers. 3(1):510–530.
   PubMedGoogle Scholar
• Nagy JA, Chang SH, Shih SC, Dvorak AM, Dvorak HF. 2010. Heterogeneity of the tumor vasculature. Semin Thromb Hemost. 36(3):321–331.
   PubMed Web of Science ®Google Scholar
• Nicolas S, Abdellatef S, Haddad MA, Fakhoury I, El-Sibai M. 2019. Hypoxia and EGF stimulation regulate VEGF expression in human glioblastoma multiforme (GBM) cells by differential regulation of the PI3K/Rho-GTPase and MAPK pathways. Cells. 8(11):1397–1421.
   PubMed Web of Science ®Google Scholar
• Obianyo O, Ye K. 2013. Novel small molecule activators of the Trk family of receptor tyrosine kinases. Biochim Biophys Acta. 1834(10):2213–2218.
   PubMed Web of Science ®Google Scholar
• Rezabakhsh A, Fathi F, Bagheri HS, Malekinejad H, Montaseri A, Rahbarghazi R, Garjani A. 2018. Silibinin protects human endothelial cells from high glucose-induced injury by enhancing autophagic response. J Cell Biochem. 119(10):8084–8094.
   PubMed Web of Science ®Google Scholar
• Rezabakhsh A, Rahbarghazi R, Malekinejad H, Fathi F, Montaseri A, Garjani A. 2019. Quercetin alleviates high glucose-induced damage on human umbilical vein endothelial cells by promoting autophagy. Phytomedicine. 56:183–193.
   PubMed Web of Science ®Google Scholar
• Riina HA, Fraser JF, Fralin S, Knopman J, Scheff RJ, Boockvar JA. 2009. Superselective intraarterial cerebral infusion of bevacizumab: a revival of interventional neuro-oncology for malignant glioma. J Exp Ther Oncol. 8(2):145–150.
   PubMedGoogle Scholar
• Roux PP, Barker PA. 2002. Neurotrophin signaling through the p75 neurotrophin receptor. Prog Neurobiol. 67(3):203–233.
   PubMed Web of Science ®Google Scholar
• Shen J, Yu Q. 2015. Gambogic amide selectively upregulates TrkA expression and triggers its activation. Pharmacol Rep. 67(2):217–223.
   PubMed Web of Science ®Google Scholar
• Singer HS, Hansen B, Martinie D, Karp CL. 1999. Mitogenesis in glioblastoma multiforme cell lines: a role for NGF and its TrkA receptors. J Neurooncol. 45(1):1–8.
   PubMed Web of Science ®Google Scholar
• Steinle JJ, Granger HJ. 2003. Nerve growth factor regulates human choroidal, but not retinal, endothelial cell migration and proliferation. Auton Neurosci. 108(1–2):57–62.
   PubMed Web of Science ®Google Scholar
• Szegezdi E, Herbert KR, Kavanagh ET, Samali A, Gorman AM. 2008. Nerve growth factor blocks thapsigargin-induced apoptosis at the level of the mitochondrion via regulation of Bim. J Cell Mol Med. 12(6A):2482–2496.
   PubMed Web of Science ®Google Scholar
• Teleanu RI, Chircov C, Grumezescu AM, Teleanu DM. 2019. Tumor angiogenesis and anti-angiogenic strategies for cancer treatment. JCM. 9(1):84–104.
   Google Scholar
• Tian W, Cao C, Shu L, Wu F. 2020. Anti-angiogenic therapy in the treatment of non-small cell lung cancer. Onco Targets Ther. 13:12113–12129.
   PubMed Web of Science ®Google Scholar
• Tian Y, Wang Z, Wang Y, Yin B, Yuan J, Qiang B, Han W, Peng X. 2020. Glioma-derived endothelial cells promote glioma cells migration via extracellular vesicles-mediated transfer of MYO1C. Biochem Biophys Res Commun. 525(1):155–161.
   Web of Science ®Google Scholar
• Varinská L, Fáber L, Kello M, Petrovová E, Balážová Ľ, Solár P, Čoma M, Urdzík P, Mojžiš J, Švajdlenka E, et al. 2018. beta-ESCIN effectively modulates HUVECS proliferation and tube formation. Molecules. 23(1):197–211.
   PubMed Web of Science ®Google Scholar
• Vera C, Tapia V, Vega M, Romero C. 2014. Role of nerve growth factor and its TRKA receptor in normal ovarian and epithelial ovarian cancer angiogenesis. J Ovarian Res. 7:82–89.
   PubMed Web of Science ®Google Scholar
• Wang J, He C, Zhou T, Huang Z, Zhou L, Liu X. 2016. NGF increases VEGF expression and promotes cell proliferation via ERK1/2 and AKT signaling in Muller cells. Mol Vis. 22:254–263.
   PubMed Web of Science ®Google Scholar
• Wang J, Yang L, Liang F, Chen Y, Yang G. 2019. Integrin alpha x stimulates cancer angiogenesis through PI3K/Akt signaling-mediated VEGFR2/VEGF-A overexpression in blood vessel endothelial cells. J Cell Biochem. 120(2):1807–1818.
   PubMed Web of Science ®Google Scholar
• Wang X, Chen W. 2012. Gambogic acid is a novel anti-cancer agent that inhibits cell proliferation, angiogenesis and metastasis. Anticancer Agents Med Chem. 12(8):994–1000.
   PubMed Web of Science ®Google Scholar
• Yi T, Yi Z, Cho SG, Luo J, Pandey MK, Aggarwal BB, Liu M. 2008. Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling. Cancer Res. 68(6):1843–1850.
   PubMed Web of Science ®Google Scholar
• Yu P, Zhang Z, Li S, Wen X, Quan W, Tian Q, Chen J, Zhang J, Jiang R. 2016. Progesterone modulates endothelial progenitor cell (EPC) viability through the CXCL12/CXCR4/PI3K/Akt signalling pathway. Cell Prolif. 49(1):48–57.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhang H, Peng T, Li D, Xu J. 2016. Melittin suppresses cathepsin S-induced invasion and angiogenesis via blocking of the VEGF-A/VEGFR-2/MEK1/ERK1/2 pathway in human hepatocellular carcinoma. Oncol Lett. 11(1):610–618.
   PubMed Web of Science ®Google Scholar
• Zhong M, Li N, Qiu X, Ye Y, Chen H, Hua J, Yin P, Zhuang G. 2020. TIPE regulates VEGFR2 expression and promotes angiogenesis in colorectal cancer. Int J Biol Sci. 16(2):272–283.
   PubMed Web of Science ®Google Scholar
• Zhou P, Qin J, Li Y, Li G, Wang Y, Zhang N, Chen P, Li C. 2017. Combination therapy of PKCζ and COX-2 inhibitors synergistically suppress melanoma metastasis. J Exp Clin Cancer Res. 36(1):115–126.
   PubMedGoogle Scholar